Similar articles

• Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.

  Arstila M, Iisalo E, Kallio V. Arstila M, et al. Ann Clin Res. 1969 May;1(1):13-21. Ann Clin Res. 1969. PMID: 4390794 Clinical Trial. No abstract available.
• Medical management of patients with angina pectoris.

  Goldstein RE, Epstein SE. Goldstein RE, et al. Prog Cardiovasc Dis. 1972 Jan;14(4):360-98. doi: 10.1016/0033-0620(72)90032-1. Prog Cardiovasc Dis. 1972. PMID: 4400516 Review. No abstract available.
• Cardio-selective beta-adrenergic inhibition by practolol in angina pectoris.

  Frick MH, Katila M. Frick MH, et al. Fortn Rev Chic Dent Soc. 1970 Sep 1;60(5):96-101. Fortn Rev Chic Dent Soc. 1970. PMID: 4393719 Clinical Trial. No abstract available.
• Clinical evaluation of practolol, a new cardioselective beta-blocking agent in angina pectoris.

  Sandler G, Clayton GA. Sandler G, et al. Br Med J. 1970 May 16;2(5706):399-402. doi: 10.1136/bmj.2.5706.399. Br Med J. 1970. PMID: 4392983 Free PMC article. Clinical Trial.
• Indirect assessment of myocardial oxygen consumption in the evaluation of mechanisms and therapy of angina pectoris.

  Amsterdam EA, Hughes JL, DeMaria AN, Zelis R, Mason DT. Amsterdam EA, et al. Am J Cardiol. 1974 May 20;33(6):737-43. doi: 10.1016/0002-9149(74)90214-8. Am J Cardiol. 1974. PMID: 4151042 Review. No abstract available.